Seiichi Sato —BIO-PROTOCOL

Home About Us For Authors Submit Protocol Archive

Akinori Takaoka Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Japan
4 protocols

Kai Li Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Japan
2 protocols

Seiichi Sato

Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Japan

2 Author merit
Reviewer merit
Editor merit

2 Protocols published

Infection of Human Hepatocyte-chimeric Mice with HBV and in vivo Treatment with εRNA

Authors: Seiichi Sato, Kai Li and Akinori Takaoka, date: 01/20/2016, view: 3362, Q&A: 0

Hepatitis B virus (HBV) can cause both acute and chronic disease in human liver with potentially high risk of cirrhosis and liver cancer. The host range of non-human primates susceptible to this virus is limited. Therefore, experimental studies with ...

More >

HBV Infection in Human Hepatocytes and Quantification of Encapsidated HBV DNA

Authors: Kai Li, Seiichi Sato and Akinori Takaoka, date: 01/20/2016, view: 5074, Q&A: 0

Human hepatic cancer cell lines such as HepG2, Huh7, and HLE cannot get infected with Hepatitis B virus (HBV) due to lack of an HBV receptor(s). Transfection with HBV genome has so far been referred as a tool to mimic HBV infection. However, since ...

More >